Differentiating progressive massive fibrosis from lung cancer is clinically and radiologically important. In the early diagnosis and differential diagnosis of lung cancer, elevated blood levels of one tumour marker (NSE) possess lower sensitivity and specificity. The gene discussed is ENO2; the disease is lung carcinoma.